22 results  1 of 2 

1 Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
Intest Res.2023;21(2):252-265.   Published online 2022 December 2     DOI: http://dx.doi.org/10.5217/ir.2022.00092
      
2 Comparison of tube-assisted mapping biopsy with digital single-operator peroral cholangioscopy for preoperative evaluation of biliary tract cancer
Tsuyoshi Takeda, Takashi Sasaki, Takafumi Mie, Takeshi Okamoto, Chinatsu Mori, Takaaki Furukawa, Yuto Yamada, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira
Clin Endosc.2022;55(4):549-557.   Published online 2022 July 28     DOI: http://dx.doi.org/10.5946/ce.2021.227
      
3 Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
Jihoon Kang, Ji-Young Lee, Sunmin Lee, Danbee Kim, Jinyeong Lim, Ha Ra Jun, Seyeon Jeon, Young-Ae Kim, Hye Seon Park, Kyu-pyo Kim, Sung-Min Chun, Hee Jin Lee, Changhoon Yoo
Cancer Res Treat.2023;55(1):219-230.   Published online 2022 April 6     DOI: http://dx.doi.org/10.4143/crt.2021.1166
      
4 Recent Updates on Endoscopic Retrograde Cholangiography-guided Intraductal Radiofrequency Ablation for Malignant Biliary Stricture
Jae Hee Cho, Sung Ill Jang, Min Young Do, Dong Ki Lee
Korean J Gastroenterol.2021;78(4):205-212.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4166/kjg.2021.121
      
5 Conversion surgery for initially unresectable extrahepatic biliary tract cancer
Moon Young Oh, Hongbeom Kim, Yoo Jin Choi, Yoonhyeong Byun, Youngmin Han, Jae Seung Kang, Heeju Sohn, Jung Min Lee, Wooil Kwon, Jin-Young Jang
Ann Hepatobiliary Pancreat Surg.2021;25(3):349-357.   Published online 2021 August 31     DOI: http://dx.doi.org/10.14701/ahbps.2021.25.3.349
      
6 Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer
Hye-Rim Seo, Ah-Rong Nam, Ju-Hee Bang, Kyoung-Seok Oh, Jae-Min Kim, Jeesun Yoon, Tae-Yong Kim, Do-Youn Oh
Cancer Res Treat.2022;54(2):541-553.   Published online 2021 August 6     DOI: http://dx.doi.org/10.4143/crt.2021.473
      
7 Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection
Lejia Sun, Yuxi Wei, Yang Chen, Wenmo Hu, Xin Ji, Haifeng Xu, Shunda Du, Haitao Zhao, Xin Lu, Xinting Sang, Shouxian Zhong, Huayu Yang, Yilei Mao
Cancer Res Treat.2021;53(2):528-540.   Published online 2020 November 23     DOI: http://dx.doi.org/10.4143/crt.2020.833
      
8 Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer
Jeesun Yoon, Seo Young Kang, Kyung-Hun Lee, Gi Jeong Cheon, Do-Youn Oh
Cancer Res Treat.2021;53(2):471-479.   Published online 2020 October 22     DOI: http://dx.doi.org/10.4143/crt.2020.577
      
9 Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3− CD4+ T Cells in Biliary Tract Cancer
Hyung-Don Kim, Jwa Hoon Kim, Yeon-Mi Ryu, Danbee Kim, Sunmin Lee, Jaehoon Shin, Seung-Mo Hong, Ki-Hun Kim, Dong‐Hwan Jung, Gi‐Won Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Baek-Yeol Ryoo, Jae Ho Jeong, Kyu-pyo Kim, Sang-Yeob Kim, Changhoon Yoo
Cancer Res Treat.2021;53(1):162-171.   Published online 2020 August 31     DOI: http://dx.doi.org/10.4143/crt.2020.704
      
10 Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer
Ah-Rong Nam, Mei-Hua Jin, Ju-Hee Bang, Kyoung-Seok Oh, Hye-Rim Seo, Do-Youn Oh, Yung-Jue Bang
Cancer Res Treat.2020;52(3):945-956.   Published online 2020 April 17     DOI: http://dx.doi.org/10.4143/crt.2020.080
      
11 Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
Ah-Rong Nam, Mei Hua Jin, Ji Eun Park, Ju-Hee Bang, Do-Youn Oh, Yung-Jue Bang
Cancer Res Treat.2019;51(3):1167-1179.   Published online 2018 December 3     DOI: http://dx.doi.org/10.4143/crt.2018.526
      
12 Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo
Cancer Res Treat.2019;51(3):901-909.   Published online 2018 October 4     DOI: http://dx.doi.org/10.4143/crt.2018.326
      
13 Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
Ah-Rong Nam, Ji-Won Kim, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Do-Youn Oh, Yung-Jue Bang
Cancer Res Treat.2019;51(3):886-900.   Published online 2018 October 1     DOI: http://dx.doi.org/10.4143/crt.2018.375
      
14 Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang
Cancer Res Treat.2018;50(4):1324-1330.   Published online 2018 January 8     DOI: http://dx.doi.org/10.4143/crt.2017.526
      
15 Usefulness of Endoscopic Transpapillary Tissue Sampling for Malignant Biliary Strictures and Predictive Factors of Diagnostic Accuracy
Hiroki Tanaka, Shimpei Matsusaki, Youichirou Baba, Yoshiaki Isono, Tomohiro Sase, Hiroshi Okano, Tomonori Saito, Katsumi Mukai, Tetsuya Murata, Hiroki Taoka
Clin Endosc.2018;51(2):174-180.   Published online 2017 August 31     DOI: http://dx.doi.org/10.5946/ce.2017.082
      
16 Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis
Jun Ho Ji, Young Saing Kim, Inkeun Park, Soon Il Lee, Rock Bum Kim, Joon Oh Park, Sung Yong Oh, In Gyu Hwang, Joung-Soon Jang, Haa-Na Song, Jung-Hun Kang
Cancer Res Treat.2018;50(3):791-800.   Published online 2017 August 23     DOI: http://dx.doi.org/10.4143/crt.2017.044
      
17 Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
Hyung Soon Park, Ji Soo Park, You Jin Chun, Yun Ho Roh, Jieun Moon, Hong Jae Chon, Hye Jin Choi, Joon Seong Park, Dong Ki Lee, Se-Joon Lee, Dong Sup Yoon, Hei-Cheul Jeung
Cancer Res Treat.2017;49(4):1127-1139.   Published online 2017 February 6     DOI: http://dx.doi.org/10.4143/crt.2016.538
      
18 CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang
Cancer Res Treat.2017;49(3):807-815.   Published online 2017 January 18     DOI: http://dx.doi.org/10.4143/crt.2016.326
      
19 Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
Jung Ho Im, Jinsil Seong, Ik Jae Lee, Joon Seong Park, Dong Sup Yoon, Kyung Sik Kim, Woo Jung Lee, Kyung Ran Park
Cancer Res Treat.2016;48(2):583-595.   Published online 2015 July 22     DOI: http://dx.doi.org/10.4143/crt.2015.091
      
20 Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim
Cancer Res Treat.2015;47(3):343-361.   Published online 2015 May 18     DOI: http://dx.doi.org/10.4143/crt.2014.308
      

 1 of 2